SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (339)8/29/1996 10:14:00 AM
From: Richard Mazzarella   of 4342
 
Bill, there was a lot more. PRLN now has a test to determine how quickly AIDS will overcome a HIV positive person. That test alone should be worth a lot of money. The company should also be able to patent the "added active ingredients" to P355. That could give them the market IMO, Merck and others can't begin to compete. The low cost of the drugs, low toxicity, and the need in the 3rd world gives PRLN the crown. No FDA crap and other expensive costs either. I have to go change my pants. Post more later.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News